Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,305 results that match your search.22,305 results
  • In the first of a two-part blog, Tom Carver considers how much IP owners and users might be charged for using the Unified Patent Court
  • The UPC Preparatory Committee discussed court fees, provisional application of the UPC Agreement, the European Patent Litigation Certificate and UPC judges at its meeting this week
  • Are you up to speed with the requirements and standards at the Patent Trial and Appeal Board? View a replay of our webinar exploring how to avoid mistakes as a petitioner or patent owner during the Second Phase, from institution to the final written decision
  • Nearly 10,000 trade mark practitioners registered for the INTA Annual Meeting in San Diego this week. Managing IP was there to record what was said, heard and seen
  • American football players and comic book villains featured in a discussion yesterday about the balance that should be struck between First Amendment protections and an individual’s right of publicity.
  • More than just a source of additional revenue, licensing can be a way to grow and expand into new markets.
  • The number of trademark professionals registered to attend this year’s Annual Meeting in San Diego topped 9,915 at 5pm yesterday, making it the largest INTA Annual Meeting to date.
  • It is the million-dollar question: how can you manage your trademark portfolio on a budget while ensuring your brand is protected? Registrants yesterday received tips for doing more with less.
  • Private practice lawyers and their clients can find ways to make alternative fee arrangements a win-win, said panelists at yesterday’s INTA Annual Meeting session, Show Me the Money: Creating Alternative Fee Arrangements That Provide Value.
  • Trademark practitioners have raised alarms about the threat that plain packaging laws pose to IP rights. In Monday’s Trademarks and Consumer Protection session, Myrtha Hurtado Rivas of Novartis argued that pharmaceuticals are already subject to similar restrictions.